OPTIMAL_1: OPTIMAL, figure 1

In raredd/kmdata: A Database of Reconstructed Individual Patient Level Data from Oncology Clinical Trials

OPTIMAL, figure 1

Description

Kaplan-Meier digitized data from OPTIMAL, figure 1 (PMID 26141208). A reported sample size of 165 for a primary endpoint of PFS in lung cancer.

Usage

OPTIMAL_1

Format

A data frame of 154 observations and 3 variables:

	time	event time (in months)
	event	OS event indicator (0: no event, 1: event)
	arm	treatment arms (erlotinib, gem_carboplatin)

Source

Zhou C, Wu YL, Chen G, et al. Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802). Ann Oncol 2015; 26: 1877–83.

Examples

summary(OPTIMAL_1)

kmplot(OPTIMAL_1)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.